Anti-GAD65 autoantibodies have also been reported in a number of different neurological diseases including Stiff person syndrome, encephalitis and epilepsy, as well as being the major autoantigen in type I diabetes [35]. This evidence concerns the gene GAD2 and nervous system disorder.